Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 2, 2020
Grant Date -
Oct 26, 2017
app pub date -
Apr 21, 2017
filing date -
Apr 21, 2016
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully